Shorts

1:00
The 2024 MS Diagnostic Criteria: More Than a Definition Update
4 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)

0:35
Building a Path Toward Neuropathy Reversal
4 months ago
by
Brian Callaghan, MD, MS

1:02
Diagnosis Is Not the Same as Treatment in Multiple Sclerosis
4 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)

1:46
How Biomarkers Can Help Clarify the MS Diagnostic Gray Zone
4 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)

1:17
RECAP: Neurology News Network - July 4th
4 months ago
by
Louie Pasculli

0:56
Debunking Nerve Pain Myths
4 months ago
by
Mitzi Joi Williams, MD

2:00
Incorporating Biomarkers as Clinical End Points in Nerve Disorder Trials
4 months ago
by
Brett Morrison, MD, PhD

2:07
MicroRNAs Emerge as Promising Biomarkers for Diabetic Neuropathy
4 months ago
by
Brett Morrison, MD, PhD

1:39
RECAP: Neurology News Network - June 27th
5 months ago
by
Louie Pasculli

2:06
SLEEP 2026: Media Training Workshop on Sleep Science
5 months ago
by
Julie Flygare, JD(+1 more)

1:03
ATMRD 2026: Understanding Demoralization in Parkinson Disease
5 months ago
by
Indu Subramanian, MD(+1 more)

2:06
PNS 2026: Debate Between iPSC and Animal Models for Neuropathy Research
5 months ago
by
Ahmet Hoke, MD, PhD

1:13
AHS 2026: Real-World INFUSE Trial of Eptinezumab in Migraine
5 months ago
by
Amaal J. Starling, MD(+1 more)

1:06
SLEEP 2026: Phase 2 Study of Alixorexton in Narcolepsy Type 2
5 months ago
by
Richard Bogan, MD, FCCP, FAASM(+1 more)

0:50
Adapting Exercise for Neurologic Conditions
5 months ago
by
Mitzi Joi Williams, MD

0:58
RECAP: Neurology News Network - June 20th
5 months ago
by
Louie Pasculli

0:35
Steps Needed to Make Diabetic Peripheral Neuropathy Reversible
5 months ago
by
Brian Callaghan, MD, MS

0:57
SLEEP 2026: Key Takeaways From New Hospital-Based Sleep Apnea Guidelines
5 months ago
by
Sunil Sharma, MD(+1 more)

1:04
SLEEP 2026: What Is a Common Sleep-Related Question?
5 months ago
by
Beth Malow, MD, MS(+1 more)

1:11
ATMRD 2026: Overlooked Symptoms of Autonomic Dysfunction in PD
5 months ago
by
Louie Pasculli(+2 more)

1:09
SLEEP 2026: AASM Guideline for Treating Chronic Insomnia
5 months ago
by
Salma Patel, MD(+1 more)

0:35
Biggest Misconceptions Regarding Immune-Mediated Small Fiber Neuropathy
5 months ago
by
Matthew Evans, BM, BCh, DPhil

0:25
Goals for Expanding Knowledge on Programmed Axon Death
5 months ago
by
Michael Coleman, PhD

0:20
Improving Basic Science Objectives for Peripheral Nerve Disorders
5 months ago
by
Carla Taveggia, PhD

0:20
Confocal Corneal Microscopy as an Emerging Biomarker for Peripheral Nerve Disorders
5 months ago
by
Brett Morrison, MD, PhD

0:32
Addressing an Overlooked Gap in MS Clinical Trials
5 months ago
by
Louie Pasculli(+1 more)

0:20
Key Areas of Neuropathy Research: Keeping and Optimizing Animal Models
5 months ago
by
Ahmet Hoke, MD, PhD

0:48
Underexplored, Emerging Biomarkers for ALS
5 months ago
by
Jinsy A. Andrews, MD, MSc

0:56
Exploring the Possibility of Treating ALS in the Prodromal Stage
5 months ago
by
Jinsy A. Andrews, MD, MSc

1:04
ATMRD 2026: Redefining Wellness in Parkinson Disease
5 months ago
by
Louie Pasculli(+1 more)
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG
2
Myelin Repair Research in MS: Lessons From Clinical Trials and the Road Ahead
3
From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease
4
FDA Requires NAION Warning Across GLP-1 Receptor Agonist Class
5
